Eisler Capital (Uk) Ltd. Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Eisler Capital (Uk) Ltd.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $1.53 Million - $1.79 Million	1,490 Added 3.51%	43,962 $46.2 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $26.4 Million - $32 Million	29,896 Added 237.72%	42,472 $44.6 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $2.76 Million - $3.04 Million	3,061 Added 32.17%	12,576 $12.1 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $6.75 Million - $7.68 Million	8,706 Added 1076.14%	9,515 $8.36 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $560,192 - $683,095	809 New	809 $665,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $15.1 Million - $20.3 Million	-27,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $7.44 Million - $8.73 Million	12,500 Added 83.33%	27,500 $19.2 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $8.15 Million - $10.1 Million	15,000 New	15,000 $9.48 Million

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.